Eurofins Scientific Balance Sheet Health
Financial Health criteria checks 4/6
Eurofins Scientific has a total shareholder equity of €5.3B and total debt of €2.9B, which brings its debt-to-equity ratio to 55.3%. Its total assets and total liabilities are €10.8B and €5.5B respectively. Eurofins Scientific's EBIT is €820.0M making its interest coverage ratio 5.8. It has cash and short-term investments of €681.2M.
Key information
55.3%
Debt to equity ratio
€2.93b
Debt
| Interest coverage ratio | 5.8x |
| Cash | €681.20m |
| Equity | €5.30b |
| Total liabilities | €5.50b |
| Total assets | €10.80b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ERFP's short term assets (€2.6B) exceed its short term liabilities (€1.8B).
Long Term Liabilities: ERFP's short term assets (€2.6B) do not cover its long term liabilities (€3.7B).
Debt to Equity History and Analysis
Debt Level: ERFP's net debt to equity ratio (42.5%) is considered high.
Reducing Debt: ERFP's debt to equity ratio has reduced from 109.6% to 55.3% over the past 5 years.
Debt Coverage: ERFP's debt is well covered by operating cash flow (41.4%).
Interest Coverage: ERFP's interest payments on its debt are well covered by EBIT (5.8x coverage).